Example: Heart Attack

Search clinical trials for: Anti-Retroviral Agents

Total 4523 results

NCT04496882

Not yet recruiting

Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue

Conditions: Chronic Hepatitis b; Hepatitis B Reactivation
NCT04493216

Not yet recruiting

A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults

Conditions: HIV Infections
NCT04489953

Completed

Comparison of Treatment Failure Criteria in HIV-Infected Children in Uganda

Conditions: HIV
NCT04487041

Not yet recruiting

Tfh Dysfunction in HIV and Aging

Conditions: Human Influenza
NCT04487145

Not yet recruiting

Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy

Conditions: Drug-Drug Interaction; HIV Infection
NCT04488081

Not yet recruiting

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Conditions: COVID-19
NCT04483674

Not yet recruiting

Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection

Conditions: HIV Primary Infection
NCT04483960

Recruiting

Australasian COVID-19 Trial (ASCOT)

Conditions: SARS-CoV-2 Infection (COVID-19)
NCT04482010

Not yet recruiting

ANRS 12392 Sanu Gundo

Conditions: HIV Infections
NCT04479475

Not yet recruiting

Social Networks and Methadone Maintenance Treatment Retention and Antiretroviral Therapy Retention in Tanzania

Conditions: Opioid-use Disorder; Adherence, Medication; HIV Infections
NCT04480554

Not yet recruiting

Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

Conditions: Opioid-use Disorder; HIV-1-infection; Immune Activation; Inflammation; Methadone; Buprenorphine; Naltrexone; Antiretroviral Treatment
NCT04477096

Not yet recruiting

Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine

Conditions: Healthy Subjects
NCT04475991

Not yet recruiting

Safety and Efficacy of Maraviroc and/or Favipiravir vs Standard Therapy in Severe COVID-19 Adults

Conditions: COVID-19
NCT04468087

Not yet recruiting

Antiviral Agents Against COVID-19 Infection

Conditions: COVID-19
NCT04468789

Not yet recruiting

Evaluation of Six-month HIV Treatment Dispensing in South Africa

Conditions: HIV
NCT04465916

Recruiting

Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)

Conditions: Hepatitis B, Chronic
NCT04466241

Not yet recruiting

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Conditions: COVID-19; COVID-19 Drug Treatment; Severe Acute Respiratory Syndrome Coronavirus 2
NCT04463784

Active, not recruiting

Efficacy of Efavirenz 400mg vs. 600mg Combined With Lamivudine and Tenofovir in Treatment Naive HIV Infection

Conditions: HIV/AIDS; Mental Impairment
NCT04460924

Not yet recruiting

ARTiBIOME: Observational Study on the Effect of HIV and ART on Gut Microbiome

Conditions: HIV Infections
NCT04459286

Not yet recruiting

The Nitazoxanide Plus Atazanavir for COVID-19 Study

Conditions: Covid-19
NCT04459598

Not yet recruiting

A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants

Conditions: Healthy Subjects; Drug-drug Interaction; Pharmacokinetics; Quizartinib
NCT04459702

Not yet recruiting

A Study of Combination Therapies to Treat COVID-19 Infection

Conditions: COVID; COVID-19; Corona Virus Infection; Coronavirus Infection; Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere; Coronavirus-19; SARS-CoV 2; SARS Pneumonia
NCT04455958

Not yet recruiting

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Symptomatic COVID-19 Infection Laboratory-Confirmed
NCT04453436

Not yet recruiting

HIV Drug Resistance Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil

Conditions: HIV; Drug; Resistance
NCT04454567

Not yet recruiting

A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors

Conditions: Chronic Hepatitis B
NCT04452565

Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Conditions: Coronavirus Infection; Severe Acute Respiratory Infection; Severe Acute Respiratory Syndrome Coronavirus 2
NCT04448158

Not yet recruiting

Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy

Conditions: HIV-1-infection
NCT04442737

Recruiting

A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

Conditions: HIV-1
NCT04441385

Recruiting

Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).

Conditions: COVID-19
NCT04439448

Completed

Adipose Tissue and Immune Activation in HIV

Conditions: Human Immunodeficiency Virus; Obesity
NCT04439539

Not yet recruiting

A Study of JNJ-73763989 + JNJ-56136379 + Nucleos(t)Ide Analog (NA) Regimen With or Without Pegylated Interferon Alpha-2a (PegIFN-α2a) in Treatment-Naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection and Normal Alanine Aminotransferase (ALT)

Conditions: Hepatitis B, Chronic
NCT04435522

Not yet recruiting

Maraviroc in Patients With Moderate and Severe COVID-19

Conditions: COVID
NCT04435587

Not yet recruiting

Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection

Conditions: Asymptomatic Infections; SARS-CoV2 Infection
NCT04431375

Recruiting

Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV

Conditions: Acute-On-Chronic Liver Failure; Hepatitis B
NCT04431518

Not yet recruiting

PK of JULUCA in Hemodialysis

Conditions: HIV/AIDS; ESRD
NCT04433780

Not yet recruiting

DORA: The Safety of Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV in South Africa

Conditions: HIV-1-infection
NCT04434248

Active, not recruiting

An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

Conditions: COVID-19
NCT04429152

Not yet recruiting

ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance

Conditions: HIV-1-infection
NCT04425382

Recruiting

Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar

Conditions: Coronavirus; COVID; Pneumonia
NCT04426669

Recruiting

A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Conditions: Gastrointestinal Epithelial Cancer; Gastrointestinal Neoplasms; Cancer of Gastrointestinal Tract; Cancer, Gastrointestinal; Gastrointestinal Cancer; Colo-rectal Cancer; Pancreatic Cancer; Gall Bladder Cancer; Colon Cancer; Esophageal Cancer; Stomach Cancer
NCT04424264

Recruiting

The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants

Conditions: HIV-1-infection; Tuberculosis
NCT04418037

Recruiting

DHFS for Medication Adherence Support During Hospital Admissions for Person Living With HIV

Conditions: HIV/AIDS
NCT04418076

Completed

Project SMART Automated Pillbox Study

Conditions: HIV/AIDS; Cocaine Use
NCT04409483

Withdrawn

Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger

Conditions: Covid-19
NCT04405271

Not yet recruiting

TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)

Conditions: Healthcare Workers; COVID-19; SARS-CoV 2
NCT04406727

Not yet recruiting

UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection

Conditions: HIV-1 Infection
NCT04403100

Recruiting

Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

Conditions: COVID-19; Coronavirus Infection; Virus Disease; Acute Respiratory Infection; SARS-CoV Infection
NCT04404049

Not yet recruiting

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

Conditions: HIV-1-infection
NCT04397107

Not yet recruiting

The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases

Conditions: Systemic Lupus Erythematosus
NCT04392700

Recruiting

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Conditions: Hepatocellular Carcinoma Recurrent

Search clinical trials for: Anti-Retroviral Agents

Recent CRA jobs

Mgr Ops (Night Shift)

Senior Logistics Coordinator - Sample Management , LIMS , GMP

Logistics Coord

Senior Pricing Specialist - Digital Teams

Sr Biostatistician I

Group Leader / Sr Group Leader

Assoc QC Auditor

Associate Scientist - Cell Lab

Commercial Coordinator - Cambridge

Senior Automation Scientist